Top 3 Health Care Stocks That Are Ticking Portfolio Bombs
Portfolio Pulse from Avi Kapoor
As of March 14, 2024, Molina Healthcare, Inc. (MOH), Apogee Therapeutics, Inc. (APGE), and CymaBay Therapeutics, Inc. (CBAY) are identified as overbought health care stocks with RSI values significantly above 70, indicating potential short-term performance concerns. MOH's RSI stands at 88.79, APGE's at 86.76, and CBAY's at 80.88, suggesting they may be due for a correction.
March 14, 2024 | 12:57 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Apogee Therapeutics shows an RSI of 86.76, hinting at a possible short-term price correction.
APGE's high RSI value suggests that the stock may be overvalued at its current price level, leading to a potential short-term correction as investors might start selling off to realize gains.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
CymaBay Therapeutics' RSI of 80.88 could indicate an impending short-term price drop.
CBAY's RSI above 70 points to an overbought condition, which typically precedes a price correction. Investors might see this as a signal to sell, potentially leading to a decrease in the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Molina Healthcare's stock is considered overbought with an RSI of 88.79, indicating potential short-term downside.
With an RSI significantly above 70, MOH is in the overbought territory, suggesting that the stock might face a pullback as traders might consider taking profits, leading to a short-term price decline.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90